PM Modi will hold a meeting of the Council of Ministers today, most likely to discuss the Omicron Surge

Today, Prime Minister Narendra Modi is hosting a meeting of the Council of Ministers, which is expected to debate steps in light of the new variation, which comes amid a worrying spike in Omicron cases in India. Despite the fact that the Prime Minister’s office has yet to publish a comment on the meeting. The meeting will be held at 4 p.m. on Wednesday, with practically all Cabinet Ministers anticipated to participate.

India has so far reported 781 cases of the Omicron form of coronavirus across 21 states and UTs, with 241 people recovering or relocating, according to statistics from the Union Health Ministry. The highest instances were found in Delhi (238), followed by Maharashtra (167), Gujarat (73), Kerala (65), and Telangana (65). (62).

The World Health Organization (WHO) warned on Tuesday that the new COVID-19 strain might overwhelm global healthcare systems, particularly in Europe and the United States, where infections are on the rise.

India has announced the availability of a vaccination for youngsters, as well as a “precaution dose” for the elderly and healthcare personnel.

PM Modi has declared that vaccination against COVID-19 will begin on January 3 for children aged 15 to 18, followed by a “precaution dosage” for healthcare and frontline workers on January 10. Following an upsurge in Corornavirus infections connected to the recently discovered and highly infectious Omicron strain, the decisions were made.

On December 25, he announced in a speech to the country that the precaution dose will be available on January 10 next year for individuals over 60 with comorbidities who seek medical counsel.

His remarks came on the same day that the Drugs Controller General of India (DCGI) revealed that Bharat Biotech’s Covaxin, an indigenously manufactured vaccine, had been granted emergency use authorization for children aged 12 and up with specified conditions. It is the second vaccination to get regulatory approval for use in children under the age of 18 after Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D.

India has announced the availability of a vaccination for youngsters, as well as a “precaution dose” for the elderly and healthcare personnel.

The number of vaccines available in India has increased to seven.

On Tuesday, the DCGI gave emergency approval to Novavax-Covovax SII vaccines, providing India’s vaccination programme a boost. In the United States, Covovax, a joint venture between Novavax and the Serum Institute of India, is still pending FDA approval.

India’s vaccine portfolio now includes Covishield, Covaxin, Sputnik V, Moderna vaccine (mRNA-1273), Janssen vaccine, ZyCoV-D, and Corbevax, as well as the capacity to import any foreign-based vaccine, such as Pfizer.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button